TRZ
Synthetic peptide analog (tirzepatide) studied for its ability to activate both the glucose-dependent insulinotropic polypeptide (GIP) receptor and the GLP-1 receptor. Known in the scientific literature as a dual incretin receptor agonist, it has been widely researched for its role in metabolic signaling pathways, energy balance studies, and endocrine-related mechanisms. GIP receptor activation influences cAMP/PKA signaling, insulin secretion in model systems, beta-cell function, and energy-balance pathways. GLP-1 receptor activation involves gastric emptying, hypothalamic appetite circuits, and glucagon modulation.
- Dual incretin receptor signaling
- Metabolic pathway investigations
- Energy balance and appetite signaling
- Glucose regulation mechanisms
- Body composition and adipose biology
Sold exclusively to licensed medical and clinical B2B accounts. Intended for professional use under the supervision of licensed practitioners.